SAN FRANCISCO--(BUSINESS WIRE)--Validant Consulting, a leading global quality, compliance and regulatory consulting group (the Group), has acquired Greenleaf Health, Inc. (Greenleaf), a leading U.S. Food and Drug Administration (FDA) regulatory consulting firm. Concurrent with the acquisition, Validant announced the appointment of Patrick Ronan, founder and former Chief Executive Officer (CEO) of Greenleaf, as the new CEO of Validant.
Validant is a California-based management consulting firm that provides services such as quality control and regulatory compliance for the life sciences industry.